Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers

Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers

Malickova K, Francova I, Lukas M, Kolar M, Kralikova E, Bortlik M, Duricova D, Stepankova L, Zvolska K, Pankova A, Zima T: Fecal zonulin is elevated in Crohn’s disease and in cigarette smokers. Pract Lab Med 2017;9:39-44.

Odkaz na článek

Další publikace

Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation
Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective
observation
přejít na článek
Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis
Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative
Colitis
přejít na článek
Tofacitinib induction efficacy and safety in ulcerative colitis at week 8 – results from clinical practice
Tofacitinib induction efficacy and safety in ulcerative colitis at week 8 – results from clinical
practice
přejít na článek
Telemedicine and inflammatory bowel disease – results of the IBD Assistant pilot project
Telemedicine and inflammatory bowel disease – results of the IBD Assistant pilot
project
přejít na článek
Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseases
Biosimilars: concept, current status, and future perspectives in inflammatory bowel
diseases
přejít na článek
POCT system for the fecal calprotectin detection in the telemonitoring of patients with inflammatory bowel disease
POCT system for the fecal calprotectin detection in the telemonitoring of patients with inflammatory bowel
disease
přejít na článek
Early vedolizumab trough levels are not associated with short-term response in patients with inflammatory bowel disease
Early vedolizumab trough levels are not associated with short-term response in patients with inflammatory bowel
disease
přejít na článek
Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical practice
Vedolizumab vs. ustekinumab as second-line therapy in Crohn’s disease in clinical
practice
přejít na článek
The efficacy and safety of budesonide MMX (Cortiment®) for long-term maintenance therapy of ulcerative colitis
The efficacy and safety of budesonide MMX (Cortiment®) for long-term maintenance therapy of ulcerative
colitis
přejít na článek
Pregnancy outcomes in women with IBD treated with biosimilar infliximab
Pregnancy outcomes in women with IBD treated with biosimilar
infliximab
přejít na článek
Biosimilar infliximab in anti-TNF naïve IBD patients – 1-year clinical follow-up
Biosimilar infliximab in anti-TNF naïve IBD patients – 1-year clinical
follow-up
přejít na článek
Budesonide MMX (Cortiment® 9 mg) in the treatment of ulcerative colitis in real clinical practice
Budesonide MMX (Cortiment® 9 mg) in the treatment of ulcerative colitis in real clinical
practice
přejít na článek
Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD clinics
Anti-SARS-CoV-2 antibody testing in IBD healthcare professionals: are we currently able to provide COVID-free IBD
clinics
přejít na článek
Testování COVID-19-co bychom měli mít na paměti
Testování COVID-19-co bychom měli mít na
paměti
přejít na článek
Evaluation of Infliximab Therapy in Children with Crohn’s Disease Using Trough Levels Predictors
Evaluation of Infliximab Therapy in Children with Crohn’s Disease Using Trough Levels
Predictors
přejít na článek
The role of steroid hormones in the development of intrahepatic cholestasis of pregnancy
The role of steroid hormones in the development of intrahepatic cholestasis of
pregnancy
přejít na článek
Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease. Biologicals
Serum trough infliximab levels: A comparison of three different immunoassays for the monitoring of CT-P13 (infliximab) treatment in patients with inflammatory bowel disease.
Biologicals
přejít na článek
Idiopatické střevní záněty a fertilita mužů
Idiopatické střevní záněty a fertilita
mužů
přejít na článek
P177 Lower vedolizumab trough levels before interval shortening are not predictive of success of the intervention
P177 Lower vedolizumab trough levels before interval shortening are not predictive of success of the
intervention
přejít na článek
P373 Telemedicine and inflammatory bowel disease: Results of the IBD assistant pilot project
P373 Telemedicine and inflammatory bowel disease: Results of the IBD assistant pilot
project
přejít na článek